Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares
The Big Market Report Take
This biotech innovator in genetic disease therapies reported a notable insider sale amid a year of dramatic share price gains.
Related Guides
Not financial advice. The Big Market Report aggregates news for informational purposes only. Nothing on this site constitutes investment advice. Equities and other securities are subject to market risk. Always do your own research and consult a qualified financial advisor before making any investment decisions. Full disclaimer →
Never miss a story
More from this section
- PayPal: Keeping It As A Possible Convexity Play For Two Reasons (Rating Upgrade)Seeking Alpha23m ago
- Randstad N.V. (RANJY) Shareholder/Analyst Call TranscriptSeeking Alpha27m ago
- Putin Is 'Messianic' About Expanding Power, Burns SaysBloomberg Markets39m ago
One Magnificent Dividend Stock Down 71%: Too Cheap Not to Buy and Hold ForeverThe Motley Fool43m ago